CGVYX:NASDAQ
American Funds Global Insight Fund Class 529-A – CGVYX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 23.67 | 0.09 (+0.38%) | 21.67 - 24.72 | 0.0 |
Market data as of 12:00AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - CGVYX
The investment seeks to provide prudent growth of capital and conservation of principal.
The fund invests primarily in common stocks of issuers around the world that the investment adviser believes have the potential for growth. It normally invests at least 80% of its net assets in equity-type securities. The fund allocates its assets among various countries, including the U.S. (but in no fewer than three countries). It invests significantly the United States (at least 40% of its net assets). The fund may invest up to 10% of its net assets in the securities of issuers based in emerging markets.
Growth of $10,000 (10 Years)
| Total Return | 8.81% |
|---|
| Yield (Trailing 12 Mo.) | 0.90% |
|---|
| Expense Ratio | 0.81% |
|---|
| Front Load | 3.50% |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $250.00 |
|---|
| Management Tenure | 14 Years |
|---|
| Fund Inception | 11/08/2019 |
|---|
Trailing Total Returns - CGVYX
as of 02/28/2025
| Timeframe | CGVYX | S&P 500 | Global Large-Stock Blend |
|---|
| 1 Month | 0.37% | -1.30% | -0.36% |
|---|
| 3 Month | 1.41% | -0.97% | -0.27% |
|---|
| Year-to-Date | 4.42% | 1.44% | 3.13% |
|---|
| 1 Year | 11.19% | 18.41% | 11.87% |
|---|
| 3 Year | 7.45% | 12.55% | 7.71% |
|---|
| 5 Year | 10.26% | 16.85% | 11.29% |
|---|
| 10 Year | 8.56% | 12.98% | 8.21% |
|---|
| Since Inception | 8.81% | 11.12% | -- |
|---|
Sector Allocation - CGVYX
as of 02/28/2025
| Basic Materials | | 3.33% |
|---|
| Consumer Cyclical | | 7.80% |
|---|
| Financial Services | | 13.61% |
|---|
| Real Estate | | 0.69% |
|---|
| Consumer Defensive | | 6.90% |
|---|
| Healthcare | | 12.50% |
|---|
| Utilities | | 4.97% |
|---|
| Communication Services | | 7.37% |
|---|
| Energy | | 3.87% |
|---|
| Industrials | | 18.02% |
|---|
| Technology | | 20.96% |
|---|
Asset Allocation - CGVYX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | 52.75 | 52.75 |
|---|
| Bond | -- | | | 0.00 | 0.00 |
|---|
| Other | -- | | | 0.00 | 0.00 |
|---|
| Foreign Stock | -- | | | 43.06 | 43.06 |
|---|
| Foreign Bond | -- | | | 0.00 | 0.00 |
|---|
| Total | -- | | | 95.81 | 95.81 |
|---|
| Cash | -- | | | 4.19 | 4.19 |
|---|
| Total Net Assets | $15.80B |
|---|
| Total Stock Holdings | 203 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - CGVYX
as of 02/28/2025
| Company | YTD Return | % of Assets |
|---|
| AVGO | -- | 3.73% |
|---|
| MSFT | -- | 2.62% |
|---|
| AAPL | -- | 2.49% |
|---|
| Novo Nordisk AS Class B | -- | 1.83% |
|---|
| AstraZeneca PLC | -- | 1.71% |
|---|
| Safran SA | -- | 1.70% |
|---|
| JPM | -- | 1.53% |
|---|
| SAP SE | -- | 1.49% |
|---|
| GOOGL | -- | 1.45% |
|---|
| TSM | -- | 1.39% |
|---|
Valuation & Growth - CGVYX
as of 02/28/2025
| Valuation | CGVYX | Category Range |
|---|
| Price/Earnings | 24.73 | |
|---|
| Price/Book | 3.89 | |
|---|
| Price/Sales | 2.92 | |
|---|
| Price/Cash Flow | 14.52 | |
|---|
| Dividend Yield | 1.93 | |
|---|
| LT Earnings | 10.2 | |
|---|
| Historical Earnings | 18.38 | |
|---|
| Sales Growth | 9.98 | |
|---|
| Cash-Flow Growth | 11.19 | |
|---|
| Book-Value Growth | 6.11 | |
|---|
